Brain-derived neurotrophic factor (BDNF) is a neurotrophin involved in neuronal survival and plasticity that binds to high-affinity receptors named TrkB. In the central nervous system, brain insults, including stress, induce modifications in BDNF messenger RNA (mRNA) expression. The present study attempted to determine in the adult rat pituitary, a peripheral structure relevant for the stress response: (1) whether BDNF and TrkB mRNA expression is influenced by different durations (15, 30, 60, 180 and 300 min) of single immobilization stress; (2) the expression of BDNF transcripts containing the different exons and their possible variations after stress exposure. Plasma corticotropin (ACTH) and corticosterone concentrations were strongly and significantly increased as early as 5 min after the stress stimulus. Using RNAse protection assay and in situ hybridization, a rapid increase in BDNF mRNA occurred at 15 min. This was accompanied by an increase in BDNF protein at 60 min, and by a rapid and significant decrease in TrkB mRNA expression observed at 15 and 30 min after stress application. RT-PCR analysis of BNDF transcripts showed strong basal expression of exons III and IV, whereas transcripts containing exons I and II seemed weakly expressed. After stress application, transcripts containing exons III and IV were rapidly and significantly increased at 30 min, whereas transcripts containing exons I and II remained unchanged. These results show that pituitary BDNF transcripts expression is differentially affected by immobilization stress.

Keywords:
Neurotrophins, Neurotrophin receptors, Molecular neuroendocrinology, Alternative splicing, Immobilization stress
1.
Lai KO, Fu WY, Ip FCF, Ip NY: Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol Cell Neurosci 1998;11:64–76.
2.
Lewin GR, Barde YA: Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289–317.
3.
Nilsson AS, Fainzilber M, Falck P, Ibanez CF: Neurotrophine-7: A novel member of the neurotrophin family from the zebrafish. FEBS Lett 1998;424:285–290.
4.
Chao MV, Hempstead BL: p75 and Trk: A two-receptor system. Trends Neurosci 1995;18:321–326.
5.
Bothwell M: Keeping track of neurotrophin receptors. Cell 1995;65:915–918.
6.
Glass DJ, Yancopoulos GD: The neurotrophins and their receptors. Trends Cell Biol 1993;3:262–268.
7.
Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M, Persson H: Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 1993;10:475–489.
8.
Barde YA: Trophic factors and neuronal survival. Neuron 1989;2:1525–1534.
9.
Lindholm D, Castrén E, Berzaghi M, Blöchl A, Thoenen H: Activity-dependent and hormonal regulation of neutrotrophin mRNA levels in the brain: Implications for neuronal plasticity. J Neurobiol 1994;25:1362–1372.
10.
McAllister AK, Katz LC, Lo DC: Neurotrophins and synaptic plasticity. Annu Rev Neurosci 1999;22:295–318.
11.
Thoenen H: Neutrotrophins and neuronal plasticity. Science 1995;270:593–598.
12.
Lindvall O, Kokaia Z, Bengzon J, Elmér E, Kokaia M: Neurotrophins and brain insults. Trends Neurosci 1994;17:490–496.
13.
Barbany G, Persson H: Regulation of neurotrophin mRNA expression in the rat brain by glucocorticoids. Eur J Neurosci 1992;4:396–403.
14.
Schaaf MJM, de Jong J, de Kloet ER, Vreugdenhil E: Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res 1998;813:112–120.
15.
Smith MA, Makino S, Kvetnansky R, Post RM: Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995;15:1768–1777.
16.
Chao HM, Sakai RR, Ma LY, McEwen BS: Adrenal steroid regulation of neurotrophic factor expression in the rat hippocampus. Endocrinology 1998;139:3112–3118.
17.
Castren E, Thoenen H, Lindholm D: Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 1995;64:71–80.
18.
Smith MA, Makino S, Kim SY, Kvetnansky R: Stress increases brain-derived neurotrophic factor messenger ribonucleic acid in the hypothalamus and pituitary. Endocrinology 1995;136:3743–3750.
19.
Lindsay RM: Brain-derived neurotrophic factor: A NGF-related neurotrophin; in Loughlin SE, Fallon JH (eds): Neurotrophic Factors. New York, Academic Press, 1993, pp 257–284.
20.
Conner JM, Yan Q, Varon S: Distribution of brain-derived neurotrophic factor in the rat pituitary gland. NeuroReport 1996;7:1937–1940.
21.
Höpker VH, Amoureux MC, Varon S: NGF and BDNF in the anterior pituitary lobe of adult rats. J Neurosci Res 1997;49:355–363.
22.
Kononen J, Soinila S, Persson H, Honkaniemi J, Höckfelt T, Pelto-Huikko M: Neurotrophins and their receptors in the rat pituitary gland: Regulation of BDNF and trk B mRNA levels by adrenal hormones. Mol Brain Res 1995;27:347–354.
23.
Benyassi A, Gavaldà A, Armario A, Arancibia S: Role of somatostatin in the acute immobilization stress-induced GH decrease in rat. Life Sci 1993;52:361–370.
24.
Givalois L, Dornand J, Mekaouche M, Solier MD, Bristow AF, Ixart G, Siaud P, Assenmacher I, Barbanel G: Temporal cascade of plasma level surges in ACTH, corticosterone and cytokines in endotoxin-challenged rats. Am J Physiol 1994;267:R167–R170.
25.
Marcilhac A, Faudon M, Anglade G, Hery F, Siaud P: An investigation of serotoninergic involvement in the regulation of ACTH and corticosterone in the olfactory bulbectomized rat. Pharmacol Biochem Behav 1999;63:599–605.
26.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–159.
27.
Aliaga E, Rage F, Bustos G, Tapia-Arancibia L: BDNF gene transcripts in mesencephalic neurons and its differential regulation by NMDA. NeuroReport 1998;9:1959–1962.
28.
Bishop JF, Mueller GP, Mouradian MM: Alternate 5′ exons in the rat brain-derived neurotrophic factor gene: Differential patterns of expression across brain regions. Mol Brain Res 1994;26:225–232.
29.
Marmigère F, Rage F, Tapia-Arancibia L, Arancibia S: Expression of mRNAs encoding BDNF and its receptors in adult rat hypothalamus. NeuroReport 1998;9:1159–1163.
30.
Ma YJ, Costa ME, Ojeda SR: Developmental expression of the genes encoding transforming growth factor alpha and its receptor in the hypothalamus of female rhesus macaques. Neuroendocrinology 1994;60:346–359.
31.
Middlemas DS, Lindberg RA, Hunter T: TrkB, a neural receptor protein-tyrosine kinase: Evidence for a full-length and two truncated receptors. Mol Cell Biol 1991;11:143–153.
32.
Ma YJ, Dissen GA, Rage F, Ojeda SR: RNase protection assay. Meth Enzymol 1996;10:273–278.
33.
Givalois L, Arancibia S, Tapia-Arancibia L: Concomitant changes in CRH mRNA levels in rat hippocampus and hypothalamus following immobilization stress. Mol Brain Res 2000;75:166–171.
34.
Li S, Givalois L, Pelletier G: Dehydroepiandrosterone administration reverses the inhibitory influence of aging on gonadotropin-releasing hormone gene expression in the male and female rat brain. Endocrine 1997;6:265–270.
35.
Fujita T, Kobayashi S, Uchida T: Secretory aspects of neurons and paraneurons. Biochem Res 1984;suppl 5:1–8.
36.
Schlegel W, Winiger BP, Mollard P, Vacher P, Wuarin F, Zahnd GR, Wollheim CB, Dufy B: Oscillations of cytosolic Ca2+ in pituitary cells due to action potentials. Nature 1987;329:719–721.
37.
Inoue K, Couch EF, Takano K, Ogawa S: The structure and function of folliculo-stellate cells in the anterior pituitary. Arch Histol Cytol 1999;62:205–218.
38.
van Haasteren G, Li S, Muda M, Susini S, Schlegel W: Calcium signalling and gene expression. J Recept Signal Transduct Res 1999;19:481–492.
39.
Chew SL: Alternative splicing of mRNA as a mode of endocrine regulation. Trends Endocrinol Metab 1997;8:405–413.
40.
Baxter GT, Radeke MJ, Kuo RC, Makrides V, Hinkle B, Hoang R, Medina-Selby A, Coit D, Valenzuela P, Feinstein SC: Signal transduction mediated by the truncated trkB receptor isoforms, trkB.T1 and trkB.T2. J Neurosci 1997;17:2683–2690.
41.
Pappas CA, Ullrich N, Sontheimer H: Reduction of glial proliferation by K+ channel blockers is mediated by changes in pHi. Neuroreport 1994;6:193–196.
42.
Pouyssegur J, Franchi A, L’Allemain G, Paris S: Cytoplasmic pH, a key determinant of growth factor-induced DNA synthesis in quiescent fibroblasts. FEBS Lett 1985;190:115–119.
43.
Rage F, Riteau B, Alonso G, Tapia-Arancibia L: Brain-derived neurotrophic factor and neurotrophin-3 enhance somatostatin gene expression through a likely direct effect on hypothalamic somatostatin neurons. Endocrinology 1999;140:909–916.
44.
Nawa H, Bessho Y, Carnahan J, Nakanishi S, Mizuno K: Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor. J Neurochem 1993;60:772–775.
45.
Nawa H, Pelleymounter MA, Carnahan J: Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J Neurosci 1994;14:3751–3765.
46.
Aloe L, Alleva E, Bohm A, Levi-Montalcini R: Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc Natl Acad Sci USA 1986;83:6184–6187.
47.
Radka SF, Holst PA, Fritsche M, Altar CA: Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 1996;709:122–130.
48.
Berg-von der Emde K, Dees WL, Hiney JK, Hill DF, Dissen GA, Costa ME, Moholt-Siebert M, Ojeda SR: Neurotrophins and the neuroendocrine brain: Different neurotrophins sustain anatomically and functionally segregated subsets of hypothalamic dopaminergic neurons. J Neurosci 1995;15:4223–4237.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.